(Q35140074)

6 August 2017

1 reference

title

Predicting oral absorption and bioavailability (English)

1 reference

6 August 2017

1 reference

Han van de Waterbeemd

series ordinal

1

1 reference

6 August 2017

Barry C Jones

series ordinal

2

1 reference

6 August 2017

publication date

1 January 2003

1 reference

Progress in medicinal chemistry

6 August 2017

published in

1 reference

6 August 2017

volume

41

1 reference

6 August 2017

page(s)

1-59

1 reference

Property-based design: optimization of drug absorption and pharmacokinetics

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Drug transport and targeting. Intestinal transport.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Carrier-mediated intestinal transport of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Intestinal peptide transport systems and oral drug availability

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

The pharmacological role of P-glycoprotein in the intestinal epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

First-pass metabolism of midazolam by the human intestine.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

The pharmacokinetics of midazolam in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Pharmacokinetics of felodipine in patients with liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Drug-like properties and the causes of poor solubility and poor permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Guidance in the setting of drug particle size specifications to minimize variability in absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

pH-metric solubility. 3. Dissolution titration template method for solubility determination

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

The fundamental variables of the biopharmaceutics classification system (BCS): a commentary

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Evaluation and prediction of drug permeation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Review of theoretical passive drug absorption models: historical background, recent developments and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Absorption of angiotensin II antagonists in Ussing chambers, Caco-2, perfused jejunum loop and in vivo: importance of drug ionisation in the in vitro prediction of in vivo absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

An integrated process for measuring the physicochemical properties of drug candidates in a preclinical discovery environment

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Combined molecular lipophilicity descriptors and their role in understanding intramolecular effects

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

An increased throughput method for the determination of partition coefficients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

pH-metric log P. II: Refinement of partition coefficients and ionization constants of multiprotic substances

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Structure-Lipophilicity Relationships of Neutral and Protonatedβ-Blockers, Part I, Intra- and Intermolecular Effects in Isotropic Solvent Systems

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Blood-brain barrier permeation: molecular parameters governing passive diffusion

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Azole endothelin antagonists. 3. Using delta log P as a tool to improve absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

A scoring scheme for discriminating between drugs and nondrugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Potential drugs and nondrugs: prediction and identification of important structural features

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Designing libraries with CNS activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Discriminating between drugs and nondrugs by prediction of activity spectra for substances (PASS).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Prediction of the intestinal absorption of endothelin receptor antagonists using three theoretical methods of increasing complexity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Property distribution of drug-related chemical databases.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Chemoinformatics - predicting the physicochemical properties of 'drug-like' molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Computational approaches towards the rational design of drug-like compound libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Drug absorption in vitro model: filter-immobilized artificial membranes. 2. Studies of the permeability properties of lactones in Piper methysticum Forst

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

High throughput prediction of oral absorption: improvement of the composition of the lipid solution used in parallel artificial membrane permeation assay

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Optimized conditions of bio-mimetic artificial membrane permeation assay

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

A general approach for the prediction of the intestinal absorption of drugs: regression analysis using the physicochemical properties and drug-membrane electrostatic interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Immobilized-artificial-membrane chromatography: measurements of membrane partition coefficient and predicting drug membrane permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Use of immobilized artificial membrane chromatography for drug transport applications

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Potential of immobilized artificial membranes for predicting drug penetration across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Determination of the passive absorption through the rat intestine using chromatographic indices and molar volume.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

1 reference

7 January 2021

Congeneric behavior in estimations of octanol-water partition coefficients by micellar electrokinetic chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Biopartitioning micellar chromatography: an in vitro technique for predicting human drug absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Quantitative structure-retention and retention-activity relationships of beta-blocking agents by micellar liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Determination of liposome partitioning of ionizable drugs by titration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

pH-metric logP 10. Determination of liposomal membrane-water partition coefficients of ionizable drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Solid-supported lipid membranes as a tool for determination of membrane affinity: high-throughput screening of a physicochemical parameter

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

SPR Biosensor Studies of the Direct Interaction between 27 Drugs and a Liposome Surface: Correlation with Fraction Absorbed in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Comparative assessment of D-xylose absorption between small intestine and large intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Intestinal absorption of peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Active transport of sodium as the source of electric current in the short-circuited isolated frog skin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Chemical approaches to improve the oral bioavailability of peptidergic molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Jejunal permeability: a comparison between the ussing chamber technique and the single-pass perfusion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Improved prediction of in vivo peroral absorption from in vitro intestinal permeability using an internal standard to control for intra- and inter-rat variability

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Drug absorption. I. An in situ rat gut technique yielding realistic absorption rates

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Intestinal Drug Absorption and Metabolism I: Comparison of Methods and Models to Study Physiological Factors of In Vitro and In Vivo Intestinal Absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

The influence of peptide structure on transport across Caco-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

The influence of plasma binding on absorption/exsorption in the Caco-2 model of human intestinal absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 2: affinities of ACE inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Analysis of drug transport and metabolism in cell monolayer systems that have been modified by cytochrome P4503A4 cDNA-expression

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Calcein accumulation as a fluorometric functional assay of the multidrug transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

A functional assay for quantitation of the apparent affinities of ligands of P-glycoprotein in Caco-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Role of transport proteins in drug absorption, distribution and excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Substructure and whole molecule approaches for calculating log P.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Prediction of Physicochemical Parameters by Atomic Contributions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Estimation of aqueous solubility in drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Estimating the water solubilities of crystalline compounds from their chemical structures alone

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Simultaneous prediction of aqueous solubility and octanol/water partition coefficient based on descriptors derived from molecular structure

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Search for predictive generic model of aqueous solubility using Bayesian neural nets.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Development of quantitative structure-property relationship models for early ADME evaluation in drug discovery. 1. Aqueous solubility

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Prediction of polar surface area and drug transport processes using simple parameters and PLS statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Experimental and computational screening models for the prediction of intestinal drug absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Correlating partitioning and caco-2 cell permeability of structurally diverse small molecular weight compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Theoretical calculation and prediction of Caco-2 cell permeability using MolSurf parametrization and PLS statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Three-Dimensional Quantitative Structure-Permeability Relationship Analysis for a Series of Inhibitors of Rhinovirus Replication

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Evaluation of physicochemical parameters important to the oral bioavailability of peptide-like compounds: implications for the synthesis of renin inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Virtual screening of intestinal drug permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Prediction of membrane permeability to peptides from calculated dynamic molecular surface properties

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Prediction of human intestinal absorption of drug compounds from molecular structure.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

The correlation and prediction of the solubility of compounds in water using an amended solvation energy relationship.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

On the partition of ampholytes: application to blood-brain distribution.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Validation of a biophysical drug absorption model by the PATQSAR system.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Prediction of drug transport processes using simple parameters and PLS statistics. The use of ACD/logP and ACD/ChemSketch descriptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Prediction of drug absorption using multivariate statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Theoretically-derived molecular descriptors important in human intestinal absorption.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Predicting the impact of physiological and biochemical processes on oral drug bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

A general pattern for substrate recognition by P-glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Structure-activity relationship of P-glycoprotein substrates and modifiers.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Structure-activity relationships of multidrug resistance reversers

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Theoretical calculation and prediction of P-glycoprotein-interacting drugs using MolSurf parametrization and PLS statistics.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Intrinsic absolute bioavailability prediction in rats based on in situ absorption rate constants and/or in vitro partition coefficients: 6-fluoroquinolones.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Species differences in metabolism and pharmacokinetics: are we close to an understanding?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Allometric issues in drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Fluconazole: interspecies scaling and allometric relationships of pharmacokinetic properties

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

A physiologically based pharmacokinetic model of zidovudine (AZT) in the mouse: model development and scale-up to humans

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Non-congeneric structure-pharmacokinetic property correlation studies using fuzzy adaptive least-squares: oral bioavailability.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

QSAR model for drug human oral bioavailability.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Predicting human oral bioavailability of a compound: development of a novel quantitative structure-bioavailability relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Molecular properties that influence the oral bioavailability of drug candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

META. 1. A program for the evaluation of metabolic transformation of chemicals.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

"Holistic" in silico methods to estimate the systemic and CNS bioavailabilities of potential chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Polar molecular surface properties predict the intestinal absorption of drugs in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2802%2941001-6

7 January 2021

10.1016/S0079-6468(02)41001-6

Identifiers

DOI

1 reference

6 August 2017

1 reference